Literature DB >> 22350371

Alport-like glomerular basement membrane changes with renal-coloboma syndrome.

Hiromi Ohtsubo1, Naoya Morisada, Hiroshi Kaito, Koji Nagatani, Koichi Nakanishi, Kazumoto Iijima.   

Abstract

BACKGROUND: Autosomal dominant mutations in paired box gene 2 (PAX2), on chromosome 10q24, are responsible for renal coloboma syndrome (RCS). The role of PAX2 in glomerular basement membrane (GBM) formation and maintenance remains unknown. CASE-DIAGNOSIS: We report a case of a 13-year-old Japanese girl who had both optic disk coloboma and renal insufficiency. Her father and sister also had both coloboma and renal dysfunction. Renal pathological findings revealed a basket-weave pattern of the GBM, which was compatible with Alport syndrome, but type IV collagen α5 staining was normal. The patient's findings of coloboma and renal dysfunction suggested that she had RCS, and genetic analysis revealed a PAX2 heterozygous mutation in exon 2 (c.76dup, p.Val26Glyfsx27) without any mutations of COL4A3, COL4A4, and COL4A5, which are responsible for autosomal and X-linked Alport syndrome.
CONCLUSIONS: PAX2 mutations may result in abnormal GBM structure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350371     DOI: 10.1007/s00467-012-2125-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  PAX2 mutations in fetal renal hypodysplasia.

Authors:  Jelena Martinovic-Bouriel; Alexandra Benachi; Maryse Bonnière; Nora Brahimi; Chantal Esculpavit; Nicole Morichon; Michel Vekemans; Corinne Antignac; Rémi Salomon; Féréchté Encha-Razavi; Tania Attié-Bitach; Marie-Claire Gubler
Journal:  Am J Med Genet A       Date:  2010-04       Impact factor: 2.802

2.  Cellular origins of type IV collagen networks in developing glomeruli.

Authors:  Dale R Abrahamson; Billy G Hudson; Larysa Stroganova; Dorin-Bogdan Borza; Patricia L St John
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

3.  Bilateral renal hypoplasia with oligomeganephronia: quantitative and electron microsopic study.

Authors:  T Morita; J Wenzl; J McCoy; J Porch; P Kimmelstiel
Journal:  Am J Clin Pathol       Date:  1973-01       Impact factor: 2.493

4.  PAX2 gene mutation in a family with isolated renal hypoplasia.

Authors:  Kaori Nishimoto; Kazumoto Iijima; Taku Shirakawa; Kousaku Kitagawa; Kenichi Satomura; Hajime Nakamura; Norishige Yoshikawa
Journal:  J Am Soc Nephrol       Date:  2001-08       Impact factor: 10.121

5.  Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +/- mutant mice.

Authors:  S Porteous; E Torban; N P Cho; H Cunliffe; L Chua; L McNoe; T Ward; C Souza; P Gus; R Giugliani; T Sato; K Yun; J Favor; M Sicotte; P Goodyer; M Eccles
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

Review 6.  Renal coloboma syndrome.

Authors:  Lisa A Schimmenti
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246

7.  The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney.

Authors:  J Favor; R Sandulache; A Neuhäuser-Klaus; W Pretsch; B Chatterjee; E Senft; W Wurst; V Blanquet; P Grimes; R Spörle; K Schughart
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux.

Authors:  P Sanyanusin; L A Schimmenti; L A McNoe; T A Ward; M E Pierpont; M J Sullivan; W B Dobyns; M R Eccles
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

Review 9.  Cell biology of the glomerular podocyte.

Authors:  Hermann Pavenstädt; Wilhelm Kriz; Matthias Kretzler
Journal:  Physiol Rev       Date:  2003-01       Impact factor: 37.312

10.  A clinico-genetic study of renal coloboma syndrome in children.

Authors:  Hae Il Cheong; Hee Yeon Cho; Jeong Hun Kim; Young Suk Yu; Il Soo Ha; Yong Choi
Journal:  Pediatr Nephrol       Date:  2007-05-31       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.